{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:03:36Z","timestamp":1789434216732,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017954","name":"Fujian Provincial Department of Finance","doi-asserted-by":"publisher","award":["2020B017"],"award-info":[{"award-number":["2020B017"]}],"id":[{"id":"10.13039\/100017954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2020QH1024"],"award-info":[{"award-number":["2020QH1024"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijrobp.2022.12.023","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T20:10:19Z","timestamp":1672258219000},"page":"666-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and\/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma"],"prefix":"10.1016","volume":"116","author":[{"given":"Xiao-Hui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Ren-Shun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Tian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-shui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-7025","authenticated-orcid":false,"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.12.023_bib0001","doi-asserted-by":"crossref","first-page":"g4797","DOI":"10.1136\/bmj.g4797","article-title":"Renal cell carcinoma","volume":"349","author":"Jonasch","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0002","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0003","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/ijms19092529","article-title":"Clinicopathologic significance of gene alteration in clear-cell renal cell carcinoma: An updated meta-analysis and review","volume":"19","author":"Kim","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0006","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S1470-2045(18)30648-X","article-title":"Genomically annotated risk model for advanced renal-cell carcinoma: A retrospective cohort study","volume":"19","author":"Voss","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0007","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2016.10.007","article-title":"Genomic Biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma","volume":"71","author":"Hsieh","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0008","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.eururo.2017.03.046","article-title":"Evolution of circulating tumor DNA profile from first-line to subsequent therapy in metastatic renal cell carcinoma","volume":"72","author":"Pal","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0009","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cllc.2015.11.002","article-title":"Association between computed tomographic features and Kirsten rat sarcoma viral oncogene mutations in patients with stage I lung adenocarcinoma and their prognostic value","volume":"17","author":"Wang","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiol.2016151455","article-title":"CT features associated with epidermal growth factor receptor mutation status in patients with lung adenocarcinoma","volume":"280","author":"Liu","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejrad.2018.11.032","article-title":"Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation","volume":"110","author":"Rizzo","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0012","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1148\/radiol.2017161845","article-title":"Non-small cell lung cancer radiogenomics map identifies relationships between molecular and imaging phenotypes with prognostic implications","volume":"286","author":"Zhou","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00330-015-3814-0","article-title":"CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer","volume":"26","author":"Rizzo","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0014","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1007\/s00330-020-07350-2","article-title":"Development of MR-based preoperative nomograms predicting DNA copy number subtype in lower grade gliomas with prognostic implication","volume":"31","author":"Zhang","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12883-020-01838-6","article-title":"Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0016","first-page":"4513","article-title":"Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features","volume":"10","author":"Shi","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0017","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.acra.2018.05.002","article-title":"Radiogenomics of clear cell renal cell carcinoma: Associations between mRNA-based subtyping and CT imaging features","volume":"26","author":"Bowen","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0018","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/RCT.0000000000001077","article-title":"Renal cell carcinoma: Predicting DNA methylation subtyping and its consequences on overall survival with computed tomography imaging characteristics","volume":"44","author":"Yu","year":"2020","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0019","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1007\/s00330-019-06049-3","article-title":"Renal cell carcinoma: Predicting RUNX3 methylation level and its consequences on survival with CT features","volume":"29","author":"Cen","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1148\/radiol.13130663","article-title":"Radiogenomics of clear cell renal cell carcinoma: Associations between CT imaging features and mutations","volume":"270","author":"Karlo","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0021","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.3390\/ijerph19084517","article-title":"Physical examination tool for swollen and tender lower limb joints in juvenile idiopathic arthritis: A pilot diagnostic accuracy study","volume":"19","author":"Fellas","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0022","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.7150\/jca.20234","article-title":"A mutation-specific microRNA signature predicts clinical outcomes in clear cell renal cell carcinoma patients with wild-type","volume":"8","author":"Ge","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0023","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0024","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.urolonc.2018.10.027","article-title":"Mutations in renal cell carcinoma","volume":"38","author":"D'Avella","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.euf.2016.06.015","article-title":"Integration of recurrent somatic mutations with clinical outcomes: A pooled analysis of 1049 patients with clear cell renal cell carcinoma","volume":"3","author":"Manley","year":"2017","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12967-022-03557-7","article-title":"The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs","volume":"20","author":"Del Re","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0027","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41467-022-29577-x","article-title":"A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population","volume":"13","author":"Qu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0028","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00261-015-0386-z","article-title":"Radiogenomics of clear cell renal cell carcinoma: Preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group","volume":"40","author":"Shinagare","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0029","article-title":"Radiomics model for predicting TP53 status using CT and machine learning approach in laryngeal squamous cell carcinoma","volume":"12","author":"Tian","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0030","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/1759-7714.13163","article-title":"Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature","volume":"10","author":"Wang","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0031","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.nicl.2017.10.030","article-title":"MRI features predict p53 status in lower-grade gliomas via a machine-learning approach","volume":"17","author":"Li","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0032","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215885","article-title":"BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma","volume":"547","author":"Langbein","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0034","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature22798","article-title":"BAP1 regulates IP3R3-mediated Ca flux to mitochondria suppressing cell transformation","volume":"546","author":"Bononi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0035","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0036","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/cdd.2017.95","article-title":"Germline BAP1 mutations induce a Warburg effect","volume":"24","author":"Bononi","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0037","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: Origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ijrobp.2022.12.023_bib0038","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","article-title":"Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade","volume":"38","author":"Motzer","year":"2020","journal-title":"Cancer Cell"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622036720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622036720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:10:13Z","timestamp":1789431013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622036720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0360301622036720"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.12.023","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and\/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}